Artialis SA

Artialis SA is a Belgian contract research and development organization (CRDO) headquartered in Liège, Belgium. The company was founded in October 2010 as a spin-off from the Bone and Cartilage Research Unit at the University of Liège. It specializes in supporting the development of healthcare solutions aimed at ensuring healthy aging, with a focus on the prevention and treatment of age-related diseases such as neurodegenerative disorders, cardiovascular diseases, and the advancement of vaccination programs. Artialis provides end-to-end R&D services across the entire product lifecycle, including biomarker development, preclinical research, clinical trials, and regulatory affairs. The company positions itself as a development partner for companies developing products that ensure the aging population remains healthy. Its full-service approach provides a seamless and efficient path from preclinical research to clinical development. According to its official website, Artialis has successfully completed 142 R&D projects and has over 14 years of industry experience. More than half of its clients (56%) return with additional projects, and the company maintains a low turnover rate of 6%, reflecting its commitment to building long-term relationships with both staff and customers. The executive team brings a combination of more than 75 years of expertise. The company's services include biotesting, preclinical research, clinical trials, and post-study consulting services such as IMPD revision, non-clinical package revision, national competent authority meeting preparation, veterinary clinical study protocol revision, and statistical analysis. Artialis serves clients in the healthcare and pharmaceutical sectors, helping them navigate the complexities of product development and regulatory compliance. Artialis is a private company. Its leadership team includes Benedikt Van Nieuwenhove (Chief Executive Officer), Berenice Costes (Chief Operating Officer), and Melanie Uebelhoer (Chief Scientific Officer). The company is based in Liège, Belgium, and operates internationally, attending over 100 scientific events to stay at the forefront of research and innovation.

Artialis SA was founded in October 2010 as a spin-off from the Bone and Cartilage Research Unit at the University of Liège in Belgium. The company was established to provide contract research and development services focused on healthy aging, leveraging the academic expertise of its founders. In its early years, Artialis built its reputation as a specialized contract research organization (CRO) with a focus on musculoskeletal and age-related diseases. The company developed capabilities in biomarker development, preclinical research, and clinical trials, positioning itself as a full-service partner for companies developing products for the aging population. By 2013, Artialis had expanded its service offerings and client base, and by 2015 it had solidified its position as a contract research and development organization (CRDO) with a comprehensive suite of services spanning the entire product lifecycle. The company continued to grow, and according to its official website, it has successfully completed 142 R&D projects and has over 14 years of industry experience. Artialis has maintained a strong focus on scientific rigor and regulatory compliance, attending over 100 scientific events to stay at the forefront of research and innovation. The company reports that more than half of its clients (56%) return with additional projects, and it maintains a low turnover rate of 6%, reflecting its commitment to building long-term relationships with both staff and customers. Today, Artialis is headquartered in Liège, Belgium, and operates internationally, providing end-to-end R&D services including biomarker development, preclinical research, clinical trials, and regulatory affairs. Its executive team, with more than 75 years of combined expertise, leads the company in its mission to be a leading partner in healthy aging product research.

• 2015

  Artialis solidified its position as a contract research and development organization (CRDO) with a comprehensive suite of services.

• 2013

  Artialis expanded its service offerings and client base.

• 2010

  Artialis started as a spin-off from the Bone and Cartilage Research Unit at the University of Liège in October 2010.

A contract research and development organization (CRDO) focused on healthy aging, providing full-service support from preclinical research to clinical development with a focus on prevention and treatment of age-related diseases.

• Biomarker Development

  Development of biomarkers for age-related diseases.

• Preclinical Research

  Preclinical research services including biotesting and post-study consulting.

• Clinical Trials

  Clinical trial management and support.

• Regulatory Affairs

  Regulatory affairs support including IMPD revision and national competent authority meeting preparation.

1. 1Artialis - Shaping the Future of Healthy Aging Researchartialis.com
2. 2Artialis - About Usartialis.com
3. 3Preclinical Research - Post-Study Servicesartialis.com
4. 4Artialis SA (Belgium) - Wikidatawikidata.org